Abremski, K., Hoess, R., & Sternberg, N. (1983). Studies on the properties of P1 sitespecific recombination: evidence for topologically unlinked products following
recombination. Cell, 32(4), 1301–1311. https://doi.org/10.1016/0092-8674(83)903112
Akatsuka, Y. (2019). BASICS OF CAR-T CELL THERAPY AND ITS FUTURE
DEVELOPMENT. 日本輸血細胞治療学会誌, 65(6), 851–857.
https://jglobal.jst.go.jp/en/detail?JGLOBAL_ID=202002239410000051
Alberts, B., Johnson, A., Lewis, J., Raff, M., Roberts, K., & Walter, P. (2008). Molecular
Biology of the Cell Fifth Edition. 1601. https://doi.org/10.1201/9780203833445
Alvarez, J. v., Febbo, P. G., Ramaswamy, S., Loda, M., Richardson, A., & Frank, D. A.
(2005). Identification of a Genetic Signature of Activated Signal Transducer and
Activator of Transcription 3 in Human Tumors. Cancer Research, 65(12), 5054–
5062. https://doi.org/10.1158/0008-5472.CAN-04-4281
Ankarcrona, M., Zhivotovsky, B., Holmström, T., Diana, A., Eriksson, J. E., Orrenius, S.,
& Nicotera, P. (1996). Lamin and beta-tubulin fragmentation precede chromatin
degradation in glutamate-induced neuronal apoptosis. Neuroreport, 7(15–17),
2659–2664. https://doi.org/10.1097/00001756-199611040-00050
Balistreri, C. R., de Falco, E., Bordin, A., Maslova, O., Koliada, A., & Vaiserman, A.
(2020). Stem cell therapy: old challenges and new solutions. Molecular Biology
Reports, 47(4), 3117–3131. https://doi.org/10.1007/S11033-020-05353-2
Barba, D., Hardin, J., Sadelain, M., & Gage, F. H. (1994). Development of anti-tumor
immunity following thymidine kinase-mediated killing of experimental brain
tumors. Proceedings of the National Academy of Sciences of the United States of
America, 91(10), 4348–4352. https://doi.org/10.1073/PNAS.91.10.4348
Bashor, C. J., Hilton, I. B., Bandukwala, H., Smith, D. M., & Veiseh, O. (2022).
Engineering the next generation of cell-based therapeutics. Nature Reviews Drug
Discovery 2022 21:9, 21(9), 655–675. https://doi.org/10.1038/s41573-022-00476-6
bluebird bio Inc. (2022). bluebird bio Receives FDA Accelerated Approval for SKYSONA®
Gene Therapy for Early, Active Cerebral Adrenoleukodystrophy (CALD) - bluebird
bio, Inc. Press Release. https://investor.bluebirdbio.com/news-releases/newsrelease-details/bluebird-bio-receives-fda-accelerated-approval-skysonar-gene
Brambrink, T., Foreman, R., Welstead, G. G., Lengner, C. J., Wernig, M., Suh, H., &
77
Jaenisch, R. (2008). Sequential expression of pluripotency markers during direct
reprogramming of mouse somatic cells. Cell Stem Cell, 2(2), 151–159.
https://doi.org/10.1016/J.STEM.2008.01.004
Bran, G. M., Stern-Straeter, J., Hörmann, K., Riedel, F., & Goessler, U. R. (2008).
Apoptosis in Bone for Tissue Engineering. Archives of Medical Research, 39(5), 467–
482. https://doi.org/10.1016/J.ARCMED.2008.02.007
Buch, T., Heppner, F. L., Tertilt, C., Heinen, T. J. A. J., Kremer, M., Wunderlich, F. T.,
Jung, S., & Waisman, A. (2005). A Cre-inducible diphtheria toxin receptor mediates
cell lineage ablation after toxin administration. Nature Methods, 2(6), 419–426.
https://doi.org/10.1038/NMETH762
Bunn, H. F. (2013). Erythropoietin. Cold Spring Harbor Perspectives in Medicine, 3(3),
a011619. https://doi.org/10.1101/CSHPERSPECT.A011619
Burns, J. C., Friedmann, T., Driever, W., Burrascano, M., & Yee, J. K. (1993). Vesicular
stomatitis virus G glycoprotein pseudotyped retroviral vectors: concentration to
very high titer and efficient gene transfer into mammalian and nonmammalian
cells. Proceedings of the National Academy of Sciences of the United States of
America, 90(17), 8033–8037. https://doi.org/10.1073/PNAS.90.17.8033
Cavazzana-Calvo, M., Hacein-Bey, S., de Saint Basile, G., Gross, F., Yvon, E., Nusbaum,
P., Selz, F., Hue, C., Certain, S., Casanova, J. L., Bousso, P., le Deist, F., & Fischer,
A. (2000). Gene therapy of human severe combined immunodeficiency (SCID)-X1
disease. Science (New York, N.Y.), 288(5466), 669–672.
https://doi.org/10.1126/SCIENCE.288.5466.669
Chen, A. X., Chhabra, A., Song, H. H. G., Fleming, H. E., Chen, C. S., & Bhatia, S. N.
(2020). Controlled Apoptosis of Stromal Cells to Engineer Human Microlivers.
Advanced Functional Materials, 30(48), 1910442.
https://doi.org/10.1002/ADFM.201910442
Chu, Y., Senghaas, N., Köster, R. W., Wurst, W., & Kühn, R. (2008). Novel caspase-suicide
proteins for tamoxifen-inducible apoptosis. Genesis (New York, N.Y. : 2000), 46(10),
530–536. https://doi.org/10.1002/DVG.20426
di Stasi, A., Tey, S.-K., Dotti, G., Fujita, Y., Kennedy-Nasser, A., Martinez, C., Straathof,
K., Liu, E., Durett, A. G., Grilley, B., Liu, H., Cruz, C. R., Savoldo, B., Gee, A. P.,
Schindler, J., Krance, R. A., Heslop, H. E., Spencer, D. M., Rooney, C. M., & Brenner,
M. K. (2011). Inducible apoptosis as a safety switch for adoptive cell therapy. The
New England Journal of Medicine, 365(18), 1673–1683.
https://doi.org/10.1056/NEJMOA1106152
Garbers, C., Aparicio-Siegmund, S., & Rose-John, S. (2015). The IL-6/gp130/STAT3
78
signaling axis: recent advances towards specific inhibition. Current Opinion in
Immunology, 34, 75–82. https://doi.org/10.1016/J.COI.2015.02.008
Gopaul, D. N., & van Duyne, G. D. (1999). Structure and mechanism in site-specific
recombination. Current Opinion in Structural Biology, 9(1), 14–20.
https://doi.org/10.1016/S0959-440X(99)80003-7
Gossen, M., & Bujard, H. (1992). Tight control of gene expression in mammalian cells by
tetracycline-responsive promoters. Proceedings of the National Academy of
Sciences of the United States of America, 89(12), 5547–5551.
https://doi.org/10.1073/PNAS.89.12.5547
Guicciardi, M. E., & Gores, G. J. (2009). Life and death by death receptors. FASEB
Journal : Official Publication of the Federation of American Societies for
Experimental Biology, 23(6), 1625–1637. https://doi.org/10.1096/FJ.08-111005
Guo, F., Gopaul, D. N., & van Duyne, G. D. (1997). Structure of Cre recombinase
complexed with DNA in a site-specific recombination synapse. Nature, 389(6646),
40–46. https://doi.org/10.1038/37925
Gurtu, V., Yan, G., & Zhang, G. (1996). IRES bicistronic expression vectors for efficient
creation of stable mammalian cell lines. Biochemical and Biophysical Research
Communications, 229(1), 295–298. https://doi.org/10.1006/BBRC.1996.1795
Hacein-Bey-Abina, S., Pai, S.-Y., Gaspar, H. B., Armant, M., Berry, C. C., Blanche, S.,
Bleesing, J., Blondeau, J., de Boer, H., Buckland, K. F., Caccavelli, L., Cros, G., de
Oliveira, S., Fernández, K. S., Guo, D., Harris, C. E., Hopkins, G., Lehmann, L. E.,
Lim, A., … Thrasher, A. J. (2014). A modified γ-retrovirus vector for X-linked severe
combined immunodeficiency. The New England Journal of Medicine, 371(15), 1407–
1417. https://doi.org/10.1056/NEJMOA1404588
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., le Deist, F., Wulffraat, N., McIntyre,
E., Radford, I., Villeval, J.-L., Fraser, C. C., Cavazzana-Calvo, M., & Fischer, A.
(2003). A serious adverse event after successful gene therapy for X-linked severe
combined immunodeficiency. The New England Journal of Medicine, 348(3), 255–
256. https://doi.org/10.1056/NEJM200301163480314
Hacein-Bey-Abina, S., von Kalle, C., Schmidt, M., McCormack, M. P., Wulffraat, N.,
Leboulch, P., Lim, A., Osborne, C. S., Pawliuk, R., Morillon, E., Sorensen, R., Forster,
A., Fraser, P., Cohen, J. I., de Saint Basile, G., Alexander, I., Wintergerst, U.,
Frebourg, T., Aurias, A., … Cavazzana-Calvo, M. (2003). LMO2-associated clonal T
cell proliferation in two patients after gene therapy for SCID-X1. Science (New York,
N.Y.), 302(5644), 415–419. https://doi.org/10.1126/SCIENCE.1088547
Hanada, K. I., Tsunoda, R., & Hamada, H. (1996). GM-CSF-induced in vivo expansion of
79
splenic dendritic cells and their strong costimulation activity. Journal of Leukocyte
Biology, 60(2), 181–190. https://doi.org/10.1002/JLB.60.2.181
Haramoto, Y., Onuma, Y., Mawaribuchi, S., Nakajima, Y., Aiki, Y., Higuchi, K., Shimizu,
M., Tateno, H., Hirabayashi, J., & Ito, Y. (2020). A technique for removing
tumourigenic pluripotent stem cells using rBC2LCN lectin. Regenerative Therapy,
14, 306–314. https://doi.org/10.1016/J.RETH.2020.03.017
Hasegawa, M., Kawai, K., Mitsui, T., Taniguchi, K., Monnai, M., Wakui, M., Ito, M.,
Suematsu, M., Peltz, G., Nakamura, M., & Suemizu, H. (2011). The reconstituted
“humanized liver” in TK-NOG mice is mature and functional. Biochemical and
Biophysical Research Communications, 405(3), 405–410.
https://doi.org/10.1016/J.BBRC.2011.01.042
Henkler, F., Behrle, E., Dennehy, K. M., Wicovsky, A., Peters, N., Warnke, C., Pfizenmaier,
K., & Wajant, H. (2005). The extracellular domains of FasL and Fas are sufficient
for the formation of supramolecular FasL-Fas clusters of high stability. The Journal
of Cell Biology, 168(7), 1087–1098. https://doi.org/10.1083/JCB.200501048
Hosokawa, N., Hara, Y., & Mizushima, N. (2006). Generation of cell lines with
tetracycline-regulated autophagy and a role for autophagy in controlling cell size.
FEBS Letters, 580(11), 2623–2629. https://doi.org/10.1016/j.febslet.2006.04.008
Inoue, B. (2001). Apoptosis : Its Biological Functions and Molecular Mechanism. Bulletin
of Kawasaki College of Allied Health Professions, 9–18.
Iuliucci, J. D., Oliver, S. D., Morley, S., Ward, C., Ward, J., Dalgarno, D., Clackson, T., &
Berger, H. J. (2001). Intravenous safety and pharmacokinetics of a novel dimerizer
drug, AP1903, in healthy volunteers. Journal of Clinical Pharmacology, 41(8), 870–
879. https://doi.org/10.1177/00912700122010771
Jainchill, J. L., Aaronson, S. A., & Todaro, G. J. (1969). Murine sarcoma and leukemia
viruses: assay using clonal lines of contact-inhibited mouse cells. Journal of Virology,
4(5), 549–553. https://doi.org/10.1128/JVI.4.5.549-553.1969
Kamusheva, M., & Milushewa, P. (2021). Rare disease patients’ needs: an up-to-date
analysis and future directions. Pharmacia, 68(4), 763–770.
https://doi.org/10.3897/pharmacia.68.e73240
Kaneko, E., Kawahara, M., Ueda, H., & Nagamune, T. (2012). Growth control of
genetically modified cells using an antibody/c-Kit chimera. Journal of Bioscience
and Bioengineering, 113(5), 641–646. https://doi.org/10.1016/J.JBIOSC.2011.12.005
Kawahara, M., Hitomi, A., & Nagamune, T. (2014). Antigen-responsive regulation of Cell
motility and migration via the signalobodies based on c-Fms and c-Mpl.
Biotechnology Progress, 30(2), 411–417. https://doi.org/10.1002/BTPR.1861
80
Kawahara, M., Kimura, H., Ueda, H., & Nagamune, T. (2004). Selection of genetically
modified
cell population
using
hapten-specific antibody/receptor chimera.
Biochemical and Biophysical Research Communications, 315(1), 132–138.
https://doi.org/10.1016/j.bbrc.2004.01.030
Kawahara, M., Natsume, A., Terada, S., Kato, K., Tsumoto, K., Kumagai, I., Miki, M.,
Mahoney, W., Ueda, H., & Nagamune, T. (2001). Replacing factor-dependency with
that for lysozyme: affordable culture of IL-6-dependent hybridoma by transfecting
artificial cell surface receptor. Biotechnology and Bioengineering, 74(5), 416–423.
https://doi.org/10.1002/BIT.1132
Kawahara, M., Ogo, Y., Ueda, H., & Nagamune, T. (2004). Improved growth response of
antibody/receptor chimera attained by the engineering of transmembrane domain.
Protein Engineering, Design & Selection : PEDS, 17(10), 715–719.
https://doi.org/10.1093/PROTEIN/GZH088
Kawahara, M., Shimo, Y., Sogo, T., Hitomi, A., Ueda, H., & Nagamune, T. (2008).
Antigen-mediated migration of murine pro-B Ba/F3 cells via an antibody/receptor
chimera. Journal of Biotechnology, 133(1), 154–161.
https://doi.org/10.1016/J.JBIOTEC.2007.09.009
Kawahara, M., Ueda, H., Morita, S., Tsumoto, K., Kumagai, I., & Nagamune, T. (2003).
Bypassing antibiotic selection: positive screening of genetically modified cells with
an antigen-dependent proliferation switch. Nucleic Acids Research, 31(7), e32.
https://doi.org/10.1093/nar/gng032
Kawahara, M., Ueda, H., Tsumoto, K., Kumagai, I., & Nagamune, T. (2004). AMEGA:
Antigen-mediated genetically modified cell amplification. Journal of Immunological
Methods, 284(1–2), 187–194. https://doi.org/10.1016/j.jim.2003.10.007
Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972). Apoptosis: a basic biological
phenomenon with wide-ranging implications in tissue kinetics. British Journal of
Cancer, 26(4), 239–257. https://doi.org/10.1038/BJC.1972.33
Kimbrel, E. A., & Lanza, R. (2020). Next-generation stem cells — ushering in a new era
of cell-based therapies. Nature Reviews Drug Discovery 2020 19:7, 19(7), 463–479.
https://doi.org/10.1038/s41573-020-0064-x
Koopman, G., Reutelingsperger, C., & Kuijten, G. (1994). Annexin V for flow cytometric
detection of phosphatidylserine expression on B cells undergoing apoptosis. Blood,
84(5), 1415–1420. https://doi.org/https://doi.org/10.1182/blood.V84.5.1415.1415
Lee, S., Kaku, Y., Inoue, S., Nagamune, T., & Kawahara, M. (2016). Growth signalobody
selects functional intrabodies in the mammalian cytoplasm. Biotechnology Journal,
11(4), 565–573. https://doi.org/10.1002/BIOT.201500364
81
Liu, W., Kawahara, M., Ueda, H., & Nagamune, T. (2008). Construction of a fluoresceinresponsive chimeric receptor with strict ligand dependency. Biotechnology and
Bioengineering, 101(5), 975–984. https://doi.org/10.1002/BIT.21961
Loonstra, A., Vooijs, M., Beverloo, H. B., Allak, B. al, van Drunen, E., Kanaar, R., Berns,
A., & Jonkers, J. (2001). Growth inhibition and DNA damage induced by Cre
recombinase in mammalian cells. Proceedings of the National Academy of Sciences
of the United States of America, 98(16), 9209–9214.
https://doi.org/10.1073/PNAS.161269798
Lozzio, C., & Lozzio, B. (1975). Human chronic myelogenous leukemia cell-line with
positive Philadelphia chromosome.
https://ashpublications.org/blood/article-abstract/45/3/321/160285
Maghsoudi, N., Zakeri, Z., & Lockshin, R. A. (2012). Programmed cell death and
apoptosis--where it came from and where it is going: from Elie Metchnikoff to the
control of caspases - PubMed. Experimental Oncology, 34(3), 146–152.
https://pubmed.ncbi.nlm.nih.gov/23069998/
Markowska, A., Kaysiewicz, J., Markowska, J., & Huczyński, A. (2019). Doxycycline,
salinomycin, monensin and ivermectin repositioned as cancer drugs. Bioorganic &
Medicinal Chemistry Letters, 29(13), 1549–1554.
https://doi.org/10.1016/J.BMCL.2019.04.045
Matsuda, T., & Cepko, C. L. (2007). Controlled expression of transgenes introduced by in
vivo electroporation. Proceedings of the National Academy of Sciences of the United
States of America, 104(3), 1027–1032. https://doi.org/10.1073/PNAS.0610155104
Matsumoto, Y., Yamaguchi, Y., Hamachi, M., Nonomura, K., Muramatsu, Y., Yoshida, H.,
& Miura, M. (2020). Apoptosis is involved in maintaining the character of the
midbrain and the diencephalon roof plate after neural tube closure. Developmental
Biology, 468(1–2), 101–109. https://doi.org/10.1016/J.YDBIO.2020.09.015
Mizuguchi, H., Xu, Z., Ishii-Watabe, A., Uchida, E., & Hayakawa, T. (2000). IRESdependent second gene expression is significantly lower than cap-dependent first
gene expression in a bicistronic vector. Molecular Therapy : The Journal of the
American Society of Gene Therapy, 1(4), 376–382.
https://doi.org/10.1006/MTHE.2000.0050
Morita, S., Kojima, T., & Kitamura, T. (2000). Plat-E: an efficient and stable system for
transient packaging of retroviruses. Gene Therapy, 7(12), 1063–1066.
https://doi.org/10.1038/SJ.GT.3301206
Nabekura, T., Otsu, M., Nagasawa, T., Nakauchi, H., & Onodera, M. (2006). Potent
vaccine therapy with dendritic cells genetically modified by the gene-silencing82
resistant retroviral vector GCDNsap. Molecular Therapy, 13(2), 301–309.
https://doi.org/10.1016/J.YMTHE.2005.09.021
Nagree, M. S., López-Vásquez, L., & Medin, J. A. (2015). Towards in vivo amplification:
Overcoming hurdles in the use of hematopoietic stem cells in transplantation and
gene therapy. World Journal of Stem Cells, 7(11), 1233–1250.
https://doi.org/10.4252/WJSC.V7.I11.1233
Nakabayashi, H., Aoyama, S., Kawahara, M., & Nagamune, T. (2016). Differentiation
signalobody: Demonstration of antigen-dependent osteoclast differentiation from a
progenitor cell line. Journal of Bioscience and Bioengineering, 122(3), 357–363.
https://doi.org/10.1016/J.JBIOSC.2016.02.010
Otto, K. G., Jin, L., Spencer, D. M., & Anthony Blau, C. (2001). Cell proliferation through
forced engagement of c-Kit and Flt-3. Blood, 97(11), 3662–3664.
https://doi.org/10.1182/BLOOD.V97.11.3662
Palacios, R., & Steinmetz, M. (1985). Il-3-dependent mouse clones that express B-220
surface antigen, contain Ig genes in germ-line configuration, and generate B
lymphocytes in vivo. Cell, 41(3), 727–734.
https://doi.org/10.1016/S0092-8674(85)80053-2
Parr, C. J. C., Katayama, S., Miki, K., Kuang, Y., Yoshida, Y., Morizane, A., Takahashi,
J., Yamanaka, S., & Saito, H. (2016). MicroRNA-302 switch to identify and
eliminate undifferentiated human pluripotent stem cells. Scientific Reports, 6,
32532. https://doi.org/10.1038/SREP32532
Pihkala, P., Kawahara, M., Ueda, H., & Nagamune, T. (2004). An antigen-mediated
selection system for mammalian cells that produce glycosylated single-chain Fv.
Biochemical and Biophysical Research Communications, 324(4), 1165–1172.
https://doi.org/10.1016/J.BBRC.2004.09.178
Ramos, C. A., Asgari, Z., Liu, E., Yvon, E., Heslop, H. E., Rooney, C. M., Brenner, M. K.,
& Dotti, G. (2010). An inducible caspase 9 suicide gene to improve the safety of
mesenchymal stromal cell therapies. Stem Cells (Dayton, Ohio), 28(6), 1107–1115.
https://doi.org/10.1002/STEM.433
Scherer, W. F. (1954). Studies on the Propagation in Vitro of Poliomyelitis Viruses. The
Journal of Immunology, 73(5), 331–336.
Schmid, I., Uittenbogaart, C. H., Keld, B., & Giorgi, J. v. (1994). A rapid method for
measuring apoptosis and dual-color immunofluorescence by single laser flow
cytometry. Journal of Immunological Methods, 170(2), 145–157.
https://doi.org/10.1016/0022-1759(94)90390-5
Slee, E. A., Zhu, H., Chow, S. C., MacFarlane, M., Nicholson, D. W., & Cohen, G. M.
83
(1996). Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK)
inhibits apoptosis by blocking the processing of CPP32. The Biochemical Journal,
315 ( Pt 1)(Pt 1), 21–24. https://doi.org/10.1042/BJ3150021
Sogo, T., Kawahara, M., Tsumoto, K., Kumagai, I., Ueda, H., & Nagamune, T. (2008).
Selective expansion of genetically modified T cells using an antibody/interleukin-2
receptor chimera. Journal of Immunological Methods, 337(1), 16–23.
https://doi.org/10.1016/J.JIM.2008.05.003
Stephen, R. L., Gustafsson, M. C. U., Jarvis, M., Tatoud, R., Marshall, B. R., Knight, D.,
Ehrenborg, E., Harris, A. L., Wolf, C. R., & Palmer, C. N. A. (2004). Activation of
peroxisome proliferator-activated receptor delta stimulates the proliferation of
human breast and prostate cancer cell lines. Cancer Research, 64(9), 3162–3170.
https://doi.org/10.1158/0008-5472.CAN-03-2760
Straathof, K. C., Pulè, M. A., Yotnda, P., Dotti, G., Vanin, E. F., Brenner, M. K., Heslop,
H. E., Spencer, D. M., & Rooney, C. M. (2005). An inducible caspase 9 safety switch
for T-cell therapy. Blood, 105(11), 4247–4254. https://doi.org/10.1182/BLOOD-200411-4564
Suda, N., Itoh, T., Nakato, R., Shirakawa, D., Bando, M., Katou, Y., Kataoka, K.,
Shirahige, K., Tickle, C., & Tanaka, M. (2014). Dimeric combinations of MafB, cFos
and cJun control the apoptosis-survival balance in limb morphogenesis.
Development (Cambridge, England), 141(14), 2885–2894.
https://doi.org/10.1242/DEV.099150
Sun, W., Shi, Q., Zhang, H., Yang, K., Ke, Y., Wang, Y., & Qiao, L. (2019). Advances in the
Techniques and Methodologies of Cancer Gene Therapy. Discovery Medicine,
27(146), 45–55.
Takashina, T., & Nakayama, M. (2007). Modifications enhance the apoptosis-inducing
activity of FADD. Molecular Cancer Therapeutics, 6(6), 1793–1803.
https://doi.org/10.1158/1535-7163.MCT-06-0522
Tanaka, K., Kawahara, M., Ueda, H., & Nagamune, T. (2009). Selection and growth
regulation of genetically modified cells with hapten-specific antibody/receptor
tyrosine kinase chimera. Biotechnology Progress, 25(4), 1138–1145.
https://doi.org/10.1002/BTPR.185
Tang, R., & Xu, Z. (2020). Gene therapy: a double-edged sword with great powers.
Molecular and Cellular Biochemistry, 474(1–2), 73–81.
https://doi.org/10.1007/S11010-020-03834-3/TABLES/2
Thomis, D. C., Marktel, S., Bonini, C., Traversari, C., Gilman, M., Bordignon, C., &
Clackson, T. (2001). A Fas-based suicide switch in human T cells for the treatment
84
of graft-versus-host disease. Blood, 97(5), 1249–1257.
https://doi.org/10.1182/BLOOD.V97.5.1249.H8001249_1249_1257
Tsiftsoglou, A. S. (2021). Erythropoietin (EPO) as a Key Regulator of Erythropoiesis,
Bone
Remodeling
and
Endothelial
Transdifferentiation
of
Multipotent
Mesenchymal Stem Cells (MSCs): Implications in Regenerative Medicine. Cells,
10(8), 2140. https://doi.org/10.3390/CELLS10082140
Tsukamoto, T., Sogo, T., Ueyama, T., Nakao, S., Harada, Y., Ihara, D., Akagi, Y., Kida, Y.
S., Hasegawa, K., Nagamune, T., Kawahara, M., & Kawamura, T. (2020). Chimeric
G-CSF Receptor-Mediated STAT3 Activation Contributes to Efficient Induction of
Cardiomyocytes from Mouse Induced Pluripotent Stem Cells. Biotechnology
Journal, 15(2), e1900052. https://doi.org/10.1002/BIOT.201900052
Urlinger, S., Baron, U., Thellmann, M., Hasan, M. T., Bujard, H., & Hillen, W. (2000).
Exploring the sequence space for tetracycline-dependent transcriptional activators:
novel mutations yield expanded range and sensitivity. Proceedings of the National
Academy of Sciences of the United States of America, 97(14), 7963–7968.
https://doi.org/10.1073/PNAS.130192197
Verrou, C., Zhang, Y., Zürn, C., Schamel, W. W. A., & Reth, M. (1999). Comparison of the
tamoxifen regulated chimeric Cre recombinases MerCreMer and CreMer. Biological
Chemistry, 380(12), 1435–1438. https://doi.org/10.1515/BC.1999.184
Wang, Y., Pang, J., Wang, Q., Yan, L., Wang, L., Xing, Z., Wang, C., Zhang, J., & Dong, L.
(2021). Delivering Antisense Oligonucleotides across the Blood-Brain Barrier by
Tumor Cell-Derived Small Apoptotic Bodies. Advanced Science (Weinheim, Baden-
Wurttemberg, Germany), 8(13), 2004929. https://doi.org/10.1002/ADVS.202004929
Westerman, K. A., & Leboulch, P. (1996). Reversible immortalization of mammalian cells
mediated by retroviral transfer and site-specific recombination. Proceedings of the
National Academy of Sciences of the United States of America, 93(17), 8971–8976.
https://doi.org/10.1073/PNAS.93.17.8971
Witthuhn, B. A., Quelle, F. W., Silvennoinen, O., Yi, T., Tang, B., Miura, O., & Ihle, J. N.
(1993). JAK2 associates with the erythropoietin receptor and is tyrosine
phosphorylated and activated following stimulation with erythropoietin. Cell, 74(2),
227–236. https://doi.org/10.1016/0092-8674(93)90414-L
Wunderlich, F. T., Wildner, H., Rajewsky, K., & Edenhofer, F. (2001). New variants of
inducible Cre recombinase: a novel mutant of Cre-PR fusion protein exhibits
enhanced sensitivity and an expanded range of inducibility. Nucleic Acids Research,
29(10), E47. https://doi.org/10.1093/NAR/29.10.E47
Xu, R., Kume, A., Matsuda, K. M., Ueda, Y., Kodaira, H., Ogasawara, Y., Urabe, M., Kato,
85
I., Hasegawa, M., & Ozawa, K. (1999). A Selective Ampli®er Gene for TamoxifenInducible Expansion of Hematopoietic Cells. The Journal of Gene Medicine, 1(4),
236–244. https://doi.org/10.1002/(SICI)1521-2254(199907/08)1:4
Yoshida, R., Kawahara, M., & Nagamune, T. (2015). Domain structure of growth
signalobodies critically affects the outcome of antibody library selection. Journal of
Biochemistry, 157(6), 497–506. https://doi.org/10.1093/JB/MVV008
Zhang, Y., Riesterer, C., Ayrall, A. M., Sablitzky, F., Littlewood, T. D., & Reth, M. (1996).
Inducible site-directed recombination in mouse embryonic stem cells. Nucleic Acids
Research, 24(4), 543–548. https://doi.org/10.1093/NAR/24.4.543
Zhao, D., Tao, W., Li, S., Chen, Y., Sun, Y., He, Z., Sun, B., & Sun, J. (2021). Apoptotic
body-mediated intercellular delivery for enhanced drug penetration and whole
tumor destruction. Science Advances, 7(16), eabg0880.
https://doi.org/https://doi.org/10.1126/sciadv.abg0880
Zheng, L., Njauw, C. N., & Martins-Green, M. (2008). A one-plasmid conditional colorswitching transgenic system for multimodal bioimaging. Transgenic Research,
17(4), 741–747. https://doi.org/10.1007/S11248-007-9160-5
Zhu, Z., Ma, B., Homer, R. J., Zheng, T., & Elias, J. A. (2001). Use of the tetracyclinecontrolled transcriptional silencer (tTS) to eliminate transgene leak in inducible
overexpression transgenic mice. The Journal of Biological Chemistry, 276(27),
25222–25229. https://doi.org/10.1074/JBC.M101512200
久保允人. (2010). サイトカインと受容体, シグナル伝達機構. 臨床検査, 54(6), 585–592.
https://doi.org/https://doi.org/10.11477/mf.1542102308
戸澗一孔. (2018). （RS-1027）ゲノム解析と超希少疾患. ARCリポート, 37.
戸邊雅則. (2018). 創薬化学の側面から見た低分子医薬の将来像 ―低分子から中分子への広
がり―. 医薬産業政策研究所
リサーチペーパー・シリーズ No. 72, 78.
日本製薬工業協会. (2016). ビジョン2『世界80億人に革新的な医薬品を届ける』. 製薬協 産
業ビジョン2025, 60.
経済産業省. (2018). 平成29年度「我が国におけるデータ駆動型社会に係る基盤整備 （｢根
本治療の実現」に向けた適切な支援のあり方の調査）報告書」. 再生医療関連報告書,
164.
86
発表論文
Tone, Y., Kawahara, M., Kawaguchi, D., Ueda, H., & Nagamune, T. (2013). Death signalobody:
inducing conditional cell death in response to a specific antigen. Human gene therapy methods, 24(3),
141–150. https://doi.org/10.1089/hgtb.2012.147
上記論文は 第 2 章に該当
Tone, Y., Kawahara, M., Hayashi, J., & Nagamune, T. (2013). Cell fate conversion by conditionally
switching the signal-transducing domain of signalobodies. Biotechnology and bioengineering, 110(12),
3219–3226. https://doi.org/10.1002/bit.24985
上記論文は 第 3 章に該当
以上
87
...
論文の公開元へ
